(NYSE: ACH) Accendra Health's forecast annual revenue growth rate of 0.69% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 5.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.88%.
Accendra Health's revenue in 2026 is $2,647,245,000.On average, 7 Wall Street analysts forecast ACH's revenue for 2026 to be $193,646,044,672, with the lowest ACH revenue forecast at $186,955,335,424, and the highest ACH revenue forecast at $202,105,562,112. On average, 7 Wall Street analysts forecast ACH's revenue for 2027 to be $199,413,897,472, with the lowest ACH revenue forecast at $189,416,285,952, and the highest ACH revenue forecast at $211,180,317,184.
In 2028, ACH is forecast to generate $208,411,747,840 in revenue, with the lowest revenue forecast at $193,953,663,488 and the highest revenue forecast at $220,947,214,592.